Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-006998
Filing Date
2025-04-03
Accepted
2025-04-03 17:14:37
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3997
  Complete submission text file 0001062993-25-006998.txt   5502
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Issuer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 CAMPUS DRIVE, 6TH FLOOR MARLBOROUGH MA 07152
Business Address
Ek John Frederick (Reporting) CIK: 0001767921 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40344 | Film No.: 25810720